Association of GCKR and MBOAT7 genetic
polymorphisms with non-alcoholic fatty liver disease

Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease

Saved in:

Bibliographic Details
Main Authors:	Swati U. Chavan, Pravin Rathi, Ameet Mandot
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-03-01
Series:	Clinical & Experimental Hepatology
Subjects:	snp nash metabolic syndrome chronic liver disease
Online Access:	https://www.termedia.pl/Association-of-GCKR-and-MBOAT7-genetic-r-npolymorphisms-with-non-alcoholic-fatty-liver-disease,80,52648,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multifocal nodular lesions in fatty liver mimicking neoplastic disease: a case report
by: Manel Moalla, et al.
Published: (2023-04-01)

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
by: Tenagne D Challa, et al.
Published: (2019-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
by: Michal Pochopien, et al.
Published: (2024-04-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
by: Lili Niu, et al.
Published: (2019-03-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

Impact of Black Pepper (Piper nigrum) Powder on Lipid Profile Parameters Among Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Beenish, et al.
Published: (2025-01-01)

Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease
by: Bridget M. Geyer, et al.
Published: (2025-01-01)

A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
by: Hao L, et al.
Published: (2025-01-01)

Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment
by: Hashim Talib Hashim, et al.
Published: (2024-10-01)

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism
by: Xue Wang, et al.
Published: (2025-01-01)

Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
by: Natchaya Polpichai, et al.
Published: (2024-12-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

A potential gateway to understanding liver disease development: peripartum lipid fluctuations in dairy cows
by: Laura Vogel, et al.
Published: (2024-11-01)

GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia
by: Tzu‐Hao Li, et al.
Published: (2025-06-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
by: Syed Mushfiq, et al.
Published: (2025-01-01)

TCF7L2 gene rs7903146 and rs12255372 polymorphism is not associated with gestational diabetes in Bangladeshi women
by: Tania Tofail, et al.
Published: (2025-04-01)

ABO exon polymorphisms are related to ischemic stroke in a Chinese Han population
by: Yi Zhong, et al.
Published: (2025-06-01)

Impact of GPC3 rs2267531 Polymorphism on Hepatocellular Carcinoma Susceptibility
by: Batchimeg Batbaatar, et al.
Published: (2025-03-01)

A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024
by: Raju Vaishya, et al.
Published: (2025-07-01)

Simulation modelling of single nucleotide genetic polymorphisms
by: Николай Николаевич Яцков, et al.
Published: (2024-08-01)

Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)

Frequency of Polymorphisms of rs2274907 of Omentin Gene and rs9770242 of Visfatin Gene in Non-Alcoholic Fatty Liver Disease in an Iranian Population
by: Mahnaz Mohammadi, et al.
Published: (2025-02-01)

Associations between a polymorphism in the pleiotropic GCKR and Age-related phenotypes: the HALCyon programme.
by: Tamuno Alfred, et al.
Published: (2013-01-01)

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems
by: Diwakar Suresh, et al.
Published: (2025-04-01)

Current Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Benny Budiman
Published: (2024-05-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints
by: Robert F. Schwabe, et al.
Published: (2025-08-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

Studies on the Association of GCK and GCKR Polymorphisms with Susceptibility to Gestational Diabetes Mellitus: A Meta-Analysis
by: Hongxia Tu, et al.
Published: (2025-01-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)